DailyIQ
DailyIQ
Last updatedjust now

MET·MetLife, Inc.

$98.26
-1.49 (-1.49%)
After Hours
High
$102.60
Open
$98.34
Market Cap
62.89B
52W High
$106.72
Low
$97.78
P. Close
$98.26
P/E
12.27
52W Low
$67.33
Fwd P/E
8.80
DailyIQ Est.
$113.04
Inst. Own.
64.0%
Short Interest
1.68%
Days to Cover
3.3
Div. Yield
2.39%
Next Ex-Div
~Feb 2
Div. Growth
12+ yrs
NewEarnings release, scored · filed Nov 4, 2026tone -12.5 vs prior release · 159 lines scoredSee the breakdown
Technical Score (1D)
67
BULLISH
News Sentiment
63
BULLISH
On Nov 5, MetLife Inc. announced its highest‑ever adjusted earnings per share of $2.85 for Q3 2026, a 22 % increase from the prior year and the company’s record quarterly figure. The same day the company reported adjusted earnings of $1.8 billion, up 17 % year‑over‑year, aided by a non‑economic accounting gain from rising interest rates. Net income rose to $2.4 billion, driven by the interest‑rate gain. Variable investment income reached $720 million, largely from private‑equity returns, surpassing the quarterly guidance of $400 million. Capital deployment remained disciplined and the direct expense ratio stayed below the full‑year goal, positioning MetLife for continued profitability.
LOW TARGET
$84 -14.5%
2 analysts
MEAN TARGET
$109 +10.8%
13 analysts
HIGH TARGET
$131 +33.3%
11 analysts
PRICE RANGE
$84.00 - $131.00
SB / B / H / S / SS
5/13/6/1/1
DAILYIQ EST.
$113.04 (+15.0%)
Sector
Financial Services
Industry
Insurance - Life
Exchange
NYQ
Country
United States
Symbol
MET
Description
MetLife, Inc. is a global financial services provider specializing in insurance, annuities, employee benefits, and asset management. The company serves a diverse international clientele through six primary operating segments, offering a wide array of products and services. Its core offerings include various life, health, and disability insurance plans, alongside retirement solutions such as annuities and pension risk transfers. MetLife also provides employee benefit programs and asset management services, catering to both individual and institutional clients. Incorporated in 1999 and headquartered in New York, the company’s extensive product portfolio and global reach position it as a significant player in the financial services sector.
Bought (1Y)
0 shares
$0
Sold (1Y)
39,795 shares
$3.5M
Kennard William E-
Award/Grant544 shares2026-10-01
HUBBARD ROBERT GLENN-
Award/Grant941 shares2026-10-01
Glaser Daniel S-
Award/Grant544 shares2026-10-01
Hay Laura J-
Award/Grant544 shares2026-10-01
Seitz Michelle-
Award/Grant544 shares2026-10-01
67/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
138.7%
Revenue CAGR
-15.2%
Debt / Equity
0.85x
Return on Equity
11.9%
Earnings Summary
In the most recent quarter, MetLife reported Q3 2026 revenue of $19.91 billion, an 11.2% year‑over‑year increase but 1.02% below the $20.11 billion consensus estimate, while earnings per share rose to $2.85, exceeding the $2.71 consensus by 5.17%. Compared to Q2 2026, revenue fell from $19.91 billion to $19.07 billion, yet EPS remained robust at $2.85 versus $2.43, indicating a slight revenue decline offset by stronger underwriting and investment gains. Over the last four quarters, MetLife has consistently beat EPS estimates in three of the four periods, with EPS growth accelerating from $1.96 in Q1 2025 to $2.85 in Q3 2026, while revenue growth has been more volatile, ranging from $18.90 billion in Q2 2025 to $19.91 billion in Q3 2026. Historically, the company has maintained a steady YoY revenue growth trajectory, with a 14.6% increase in Q3 2026, and has frequently outperformed analyst expectations on earnings, even when net premiums earned lagged slightly behind estimates. Recent news highlights a 12% increase in total premiums, fees and other revenues to $14.1 billion in Q3 2026 and record performance across all business segments, underscoring the resilience of its underwriting and investment strategies.

EPS

EstBeatMiss
$2.18$2.37$2.56$2.75$2.94Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$2.64 - -
Q3'26$2.80$2.85+1.7%
Q2'26$2.29$2.43+6.2%
Q1'26$2.27$2.42+6.6%
Q4'25$2.37$2.58+9.1%
Q3'25$2.32$2.37+2.2%

Revenue

EstBeatMiss
$16.4B$19.7B$23.0B$26.2B$29.5BQ3'25Q4'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$20.9B - -
Q3'26$20.2B$19.9B-1.3%
Q2'26$19.9B$19.1B-4.2%
Q1'26$19.4B$19.7B+1.3%
Q4'25$28.0B$24.2B-13.6%
Q3'25 - $17.9B -

Market Data

MET Stock Snapshot

BULLISH67/100
$98.27+$0.01 (0.0%)
Market cap
62.89B
P/E ratio
12.3
Day range
$97.78 – $102.60
News sentiment
63/100 · Bullish
Analyst target
$108.88 (+10.8%)
Consensus
Buy · 26 analysts
52-week range+46.0% off low · -7.9% from high
$67.33$106.72
Price $98.27 DailyIQ Est. $113.04

Price is in the upper part of its 52-week range, and the momentum read backs that positioning up. Earnings and guidance carry more weight than macro data at this capitalisation.

Behaviour On Record

What MET's own history says about today's numbers

Realized volatility (21d)
26.0% 66th pct
Below its peak
-4.9%
vs 200-day average
+14.1%
Up days (1y)
52%

MetLife, Inc. is currently running 26.0% annualised volatility over the last 21 sessions. Measured against MET's own 13 years of daily returns rather than a market-wide average, that is the 66th percentile — a little above its own norm, against a typical reading of 23.0%.

MET is trading -4.9% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -20.1%, and the deepest was -55.3% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +14.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 88th percentile — a wider gap than this stock usually carries. Over the past year MET closed higher on 52% of sessions, and it is currently 2 sessions into a falling streak.

On November specifically: over 13 years of records, MET finished the month higher 10 of 13 times, with a median return of +3.7% and an average of +4.8%. Its strongest month historically has been November at +4.8% on average, its weakest March at -3.4%.

Overnight risk is measurable too: MET has opened more than 2% away from the prior close in 110 of 3,267 sessions (3.4% of the time), with the largest gaps running +5.9% and -8.3%.

Across the last 4 dated reports on file, MET moved an average of 2.9% in the session after earnings, closing higher 1 of those 4 times, with a median move of -2.3% and a largest of +3.8%.

All figures computed from 3,268 daily closes between 2013-11-08 and 2026-11-06, split-adjusted, recomputed daily. Percentiles are against MET's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MET's sector?

MetLife, Inc. sits in the Financials sector, currently ranked 6th of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Insurance industry group, MET ranks 4th of 15 tracked industries, leading.

Sector rank
#6 of 12
Sector state
Leading
Sector rotation score
64
Industry rank
#4 of 15

Options Market

What is the options market pricing for MET?

CallsPuts

For MetLife, Inc.'s nearest expiry (2026-11-20, 13 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.73), with at-the-money implied volatility around 35.9%. The options market is pricing roughly a ±6.9% move by that expiry — a range of about $92.72–$106.38.

Put/call ratio (2026-11-20)
0.73
ATM implied volatility
35.9%
Total open interest
9,325
Expected move by 2026-11-20
±6.9% ($92.72–$106.38)

Analyst Consensus Estimates

What do analysts expect MET to earn?

Analysts expect MetLife, Inc. to earn $10.22 per share in the fiscal year ending Dec 2026 and $11.84 in the fiscal year ending Dec 2028, from 5 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Quarter endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Sep 2026$2.77$2.62 to $2.9216$19.97B7
Dec 2026$2.62$2.49 to $2.7713$20.46B6
Mar 2027$2.57$2.39 to $2.756~$19.89B-
Jun 2027$2.80$2.63 to $2.926~$21.67B-
Sep 2027$2.77$2.62 to $2.886~$21.44B-
Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$10.22$10.02 to $10.4517$79.68B9
Dec 2027$11.16$10.76 to $11.6117$82.96B9
Dec 2028$11.84$10.24 to $12.395~$91.63B-

Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.

Analyst Rating Changes

Are analysts turning bullish or bearish on MET?

TD Cowen most recently reiterated its rating on MetLife, Inc. to Buy on Oct 21, 2026 with a price target of $114 (from $110). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.

Latest action
TD Cowen: Buy
90-day upgrades
1
90-day downgrades
0
Net rating momentum
+1
DateFirmActionRatingPrice target
Oct 21, 2026TD CowenMaintainedBuy$110 → $114
Oct 15, 2026JP MorganMaintainedOverweight$108 → $110
Oct 12, 2026Wells FargoMaintainedOverweight$109 → $110
Oct 7, 2026MizuhoMaintainedOutperform$112 → $109
Oct 7, 2026BarclaysMaintainedOverweight$97 → $111
Oct 6, 2026UBSMaintainedBuy$105 → $110
Oct 5, 2026TD CowenMaintainedBuy$105 → $110
Sep 22, 2026Piper SandlerUpgradeNeutral → Overweight$99 → $110
Aug 24, 2026Morgan StanleyMaintainedOverweight$103 → $111
Aug 19, 2026Wells FargoMaintainedOverweight$101 → $109
Aug 11, 2026JP MorganMaintainedOverweight$106 → $108
Aug 11, 2026Keefe, Bruyette & WoodsMaintainedOutperform$105 → $108

Earnings Release, Scored

What did MetLife, Inc.'s latest earnings release say?

Filed Nov 4, 2026 · SEC Form 8-K, Exhibit 99

Tone62.3/ 100-12.5 vs prior release
Hedging words0.88per 100 words+0.53 vs prior release
Tone, last 3 releasesScale 50–85

Most important lines

  1. 1

    increased 12% to $14.1 billion .

    New this quarter
  2. 2

    $13.5 billion , up 8 percent .

    New this quarter
  3. 3

    Net income was $2.4 billion , driven by net derivative gains and higher adjusted earnings.

    New this quarter

Peers & ETF holders

MET peers & ETF holders

News & sentiment

What is the news saying about MET?

MET rose 1.1% over the month to Nov 6. News tone held between 30 and 100 from Oct 6 to Oct 15, then jumped to 94 on Oct 16.

Daily close and news tone, Oct 6 to Nov 6
$95$100Oct 6: tone 67Oct 7: tone 57Oct 8: tone 100Oct 9: tone 47Oct 12: tone 32Oct 13Oct 14: tone 92Oct 15: tone 30Oct 16: tone 95Oct 19: tone 51Oct 20: tone 56Oct 21: tone 70Oct 22: tone 70Oct 23Oct 26: tone 70Oct 27: tone 39Oct 28: tone 44Oct 29: tone 75Oct 30: tone 95Nov 2: tone 50Nov 3Nov 4: tone 57Nov 5: tone 61Nov 6: tone 96Oct 6News toneNov 6123
  1. Oct 8 +2.8%
  2. Oct 23 -4.4%
  3. Nov 5 -3.0%same day: MetLife (MET) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Latest stories naming MetLife

Technical analysis

How strong is MET's momentum right now?

On the daily chart MET ranks at the 67th percentile for momentum against 1,060 stocks and ETFs, a bullish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling MET?

97 of the 213 tracked managers added to MET in their latest 13F and 113 trimmed. Together they own 64.0% of the company, worth $35.2B. BlackRock and Dodge & Cox alone hold 15.7%.

97adding113trimming3unchanged
Largest holders by stake, latest 13FBar = share of MET
  1. $4.4B positionAdded 0.7% last quarter
  2. $4.1B positionTrimmed 5.3% last quarter
  3. $3.0B positionTrimmed 1.0% last quarter
  4. $2.5B positionTrimmed 2.5% last quarter
  5. $2.1B positionAdded 0.5% last quarter
  6. $1.1B positionAdded 12.7% last quarter
  7. $1.2B positionTrimmed 7.2% last quarter
  8. $995.4M positionTrimmed 5.0% last quarter
  9. $714.5M positionAdded 5.5% last quarter
  10. $586.3M positionAdded 0.2% last quarter
Full holdings history

Congressional trading

Is Congress trading MET?

7 members of Congress disclosed 12 MET trades between Nov 10, 2014 and Mar 27, 2026: 6 buys and 6 sells, about $230.0K in estimated value.

BuysSells201620182020202220242026
BuySell$1K–$15K$15K–$50K$50K–$100K$100K–$250K

What stands out

Click one to highlight its trades in the chart

Discover more

How has MET done against its peers?

Over the six months to Nov 6, MET returned +22.7%. Of the 15 related stocks and ETFs, 3 did better, led by AJG at +41.0%.

Change since May 6, through Nov 6
−20%0%+20%+40%+60%May 6JunJulAugSepOctNov 6AJG +41.0%MET +22.7%SLF −2.1%